{"entity":{"id":"hangzhou-hanx-biopharmaceuticals","kind":"company","name":"Hangzhou Hanx Biopharmaceuticals","aka":["Hangzhou Hanx Biopharmaceuticals, Ltd."],"tldr":"Hangzhou Hanx Biopharmaceuticals is a China-based biotechnology company running 2 late-stage cancer trials of HX009 in glioma & glioblastoma, biliary tract cancer and melanoma.","summary":"Hangzhou Hanx Biopharmaceuticals, based in Wuhan, China, is a biotechnology company. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing HX009 in glioma & glioblastoma, biliary tract cancer and melanoma. The largest, NCT06708663 (HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours), plans to enrol 124 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.hanxbio.com"},{"label":"ClinicalTrials.gov: trials led by Hangzhou Hanx Biopharmaceuticals","url":"https://clinicaltrials.gov/search?lead=Hangzhou%20Hanx%20Biopharmaceuticals%2C%20Ltd."}],"tags":["ctgov-sponsor"],"related":[],"cancers":["glioblastoma","cholangiocarcinoma","melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06649708","nct06708663","nct06703255"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Wuhan","country":"CN","companyType":"biotech","website":"https://www.hanxbio.com","investors":[],"funding":[]},"route":"/companies/hangzhou-hanx-biopharmaceuticals/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"},{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"}],"trial":[{"id":"nct06703255","kind":"trial","name":"A Phase 2 Study of HX301 in Patients with High-grade Giloma","route":"/trials/nct06703255/"},{"id":"nct06708663","kind":"trial","name":"HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours","route":"/trials/nct06708663/"},{"id":"nct06649708","kind":"trial","name":"HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies","route":"/trials/nct06649708/"}]}}